A New Approach to the Development of Disease-Modifying Therapies for PD
Mov Disord
.
2021 May;36(5):1281.
doi: 10.1002/mds.28589.
Author
David K Simon
1
Affiliation
1
Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
PMID:
33991445
DOI:
10.1002/mds.28589
No abstract available
Keywords:
Parkinson's disease; clinical trial; disease modifying; neuroprotection.
Publication types
Letter
Comment
MeSH terms
Humans
Neuroprotective Agents*
Pandemics
Parkinson Disease*
Substances
Neuroprotective Agents